Partnership with WuXi Advanced Therapies to manufacture lentiviral vectors for phase I trial of cutting edge HEMO-CAR-T programme
Hemogenyx Pharma Plc (HEMO.L) HEMO-CAR-T pre-IND Meeting Request
Hemogenyx Pharmaceuticals plc (LSE: HEMO), the biopharmaceutical group developing new therapies and treatments for blood diseases.
Hemogenyx Pharma Plc (HEMO.L) Lease of New York Mink Building Custom Laboratory
Hemogenyx Pharmaceuticals has signed a lease with The Janus Property Company (“Janus”) for a new custom-designed and built laboratory in the Mink Building, located in the Manhattanville Factory District of
Hemogenyx Pharma Plc (HEMO.L) CDX Licence Agreement
Hemogenyx Pharmaceuticals plc (LSE: HEMO), the biopharmaceutical group developing new therapies and treatments for blood diseases, announces that it has signed a licence agreement (the “Agreement”) with the global biopharmaceutical
Hemogenyx Pharma Plc (HEMO.L) U.S. Approval and Issuance of CDX Antibody Patent
Hemogenyx Pharmaceuticals plc (LSE: HEMO), the biopharmaceutical group developing new therapies and treatments for blood diseases, is pleased to announce that a patent application.
Hemogenyx Pharma Plc (HEMO.L) Termination of Mint Facility; Admission of Shares
Hemogenyx Pharmaceuticals plc (LSE: HEMO), the biopharmaceutical group developing new therapies and treatments for deadly blood diseases, announces that, pursuant to the redemption, sale and conversion of convertible unsecured loan
Dr Vladislav Sandler, CEO & Co-Founder of Hemogenyx Pharmaceuticals (HEMO.L) Interview
H.C. Wainwright Investment Conference
Share Talk Weekly Stock Market News, 19th July 2020
Share Talk highlighted nine, yes nine new company “52-wk high” across our social media platforms, who said private/retail investors do not like the small micro-cap space.
Share Talk Weekly Stock Market News, 11th July 2020
Share Talk highlighted eight new company 52-wk high across our platform and liquidity, volume continues to grow across the small micro-cap market. Launching a new #BulletinBoardHeroes, USA Penny Stock Chart
Hemogenyx Pharma Plc (HEMO.L) New Corporate Video and Investor Webinar
Hemogenyx Pharmaceuticals plc (LSE: HEMO), the biopharmaceutical group developing new therapies and treatments for blood diseases.
Hemogenyx Pharma Plc (AIM:HEMO) Development Agreement
Hemogenyx to work with Global pharmaceutical company on CDX antibodies development
Hemogenyx Pharma Plc (AIM:HEMO) Collaboration with major US biotechnology company
Collaboration to further develop humanized mice as a tool for drug development and testing Hemogenyx Pharmaceuticals Plc (LSE: HEMO), the biotechnology company developing novel therapies to transform bone marrow,